Is semaglutide with B12 safe
described a patient with retrocaval MMNST who experienced decreased pain and disease stabilization with pembrolizumab prior to resection [35]
The scientific community remains cautiously optimistic
What the Research Shows Recent research on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has revealed concerning trends about body composition changes: A 2023 analysis of STEP trial data found that approximately 39% of weight lost on semaglutide was lean body mass 1 Research on tirzepatide showed similar patterns, with 30-40% of total weight loss coming from lean tissue 2 Comparative studies indicate GLP-1 users may lose more muscle than people losing weight through diet and exercise alone 3 For context: if you lose 50 pounds on a GLP-1 medication, 15-20 pounds might be muscle mass

Learn About Retatrutide Dose Escalation Chart & Units Calculator for Weight Loss Clinical Trial Data The Most Impressive to Date In a pivotal study published in the New England Journal of Medicine , Retatrutide produced: 24% average body-weight reduction in 48 weeks ( in non-diabetic participants ) For comparison: Semaglutide ~15% Tirzepatide ~21% Retatrutide 24%+ That is a level of weight loss previously achievable mostly with surgery
At TrimRx, the providers we partner with are available to help you navigate these challenges